Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The statement in bold below is NOT true. There were 7 institutional investors as of 12/31/13 and 7 institutional investors as of 3/31/14.
davidc2 said...
It's about time!
Am I correct that the only anti-fungal compounds we have were part of the Poly purchase? Is it a B related compound?
Alexwv said...
It could also be that by "stabilization", he/she is just talking about that one specific type of cancer.
Kevetrin could be putting other types of cancer into remission...
@Tom - Has anything changed your outlook on GALT since your May 30 update? TIA
That is my recollection as well.
BK said...
Isn't there a provision of patent law that adds time to a drug patent to offset the time lost to the FDA approval process?
iamactixaddict said...
It's a wonder any new drug ever makes it to market. The excerpts below reveal that the FDA is an incompetent bureaucracy at best or a bureaucracy tainted by outside influences at worst. It is disturbing that the FDA is going to such lengths to STIFLE new drug development.
The FDA was WRONG in EVERY assumption they made in the three meetings with Provectus described below. In this case the FDA has singlehandedly added 4 years to the approval process for this drug. How many people have died and will die because of this FDA generated clusterfu*k? And yet they still seek to delay bringing this drug to market. UNBELIEVEABLE!
From the conference call...
AND INSURANCE COMPANIES SHOULD BE REQUIRED TO PAY FOR THE TREATMENT IF THE TREATMENT HAS A POSITIVE OUTCOME!
vorlon1966 said....
So you live on Oahu!!
So true... So true...
Leifsmith said...
My thoughts exactly...
DirectionalDriller said...
Once we finish this Phase 1 trial for NASH and assuming that there were no safety issues; will we also have to do Phase 1's for kidney and lung fibrosis? Or will we be able to skip Phase 1 and proceed directly with Phase 2 trials for those conditions? TIA
DirectionalDriller said...
I have been "wondering" much the same thing. That's one reason I like the compassionate use program. People who have otherwise exhausted their treatment options could try the drug regardless of the cause of their liver fibrosis/cirrhosis. It would be nice to find out if GR-MD-02 will reverse any and all liver fibrosis/cirrhosis or just some.
Darwinian said...
I don't fault your decision. It obviously paid off for you. However, he disposed of those 25,000 options by exercising them. That means he bought 25,000 shares. His share count and his total investment in the company INCREASED.
maxpow said...
Except that he was exercising options at $1.25. His actual share ownership went up, not down.
maxpow said...
So if management is telling the truth that they had not heard from the FDA, how did Feuerstein know? There have been reports that AF has inserted himself in the FDA process for at least one other drug. Is this what has happened here? If management can prove what they say about when they were notified by the FDA, then I think that AF has some explaining to do.
Who would have jurisdiction in a case like this, the FDA, the SEC, or both?
On the other hand, if someone can prove that management is lying, then those shareholder lawsuits will have merit. IMO AF has sufficiently demonstrated his lack of character. So between AF and PVCT management, at this point I choose to believe management.
tommsel1 said...
After reading the Denial Letter, I wondered if those "existing therapies" have available data on those "clinically significant endpoints" of "pain, infection, or significant bleeding." Apparently, these were not clinical "endpoints" that the FDA considered significant previously. That being the case, why would the testing for those existing therapies have bothered to track those "endpoints"? That could make it very difficult for PVCT to compare those "clinically significant endpoints" for PV-10 to those of the existing therapies.
Ovidius said...
That was the question I wanted clarified. I think that there may be some validity to the argument that PVCT should also seek approval in a less restrictive jurisdiction. Such approval would allow PVCT to sell PV-10 in that jurisdiction thus forever resolving the company's cashflow concerns.
And as word spreads of PV-10's efficacy, wealthy patients and/or PVCT investors from western countries will travel to said jurisdiction for treatment.
buccaneer asked...
I tried to ask about this strategy on the conference call but for some reason it would not recognize me during the Q&A.
Groscoe said...
....
Apparently the FDA wrote the letter on May 16 and our FDA "contact" was supposed to forward an electronic copy to management. But according to management, that electronic correspondence did not happen until they called their FDA "contact" for an update on the 21st.
The problem is that the shorts seemed to have this information last week. Did AF and friends get a copy of the May 16 letter before PVCT's management? If so, how?
If AF and crew traded based on non-public information, then they should be required to spend some time at the Martha Stewart Institution for Insider Trading, otherwise known as prison.
I don't want to burst your bubble, but those other companies CURRENTLY don't have this "short attack nonsense to deal with". That does NOT mean that they will NOT have "to deal with" it in the future. I have the privilege of owning 4 stocks at which AF has fired his poison. I am currently above my cost basis in three of them. (However PVCT is one of them so that may be about to change.)
Given that the SEC is letting this organized short manipulation go unchecked, I think we are going to see this short manipulation happen with virtually every promising small biotech company.
EODparty7...
I agree that the FDA decision makes no sense. However, I've been around long enough to know that bureaucracies are often wrong. Sometimes it's just the natural tendency of a bureaucrat to always say "No". Sometimes bureaucrats use a twisted form of logic that makes no sense in the real world. And sometimes bureaucrats are "influenced" to make decisions that benefit other "interested parties". Unfortunately these things happen.
Because I thought the chances were good that we would get BTD, I did move PVCT up on my acquisition priority list. And I am not happy that we did not get BTD. However, I have posted previously that my decision to invest in PVCT was not because of the BTD application. I believe in PV-10 and in the scientists involved so I am willing to wait a little longer.
If your investment was based solely on getting BTD, then perhaps you should sell.
SJI88 said...
It's your call. But I plan to hold and maybe add on the drop. I still believe in PV-10. The timeframe to monetization just got extended. We'll see what the spin is on the conference call this afternoon.
SJI88 asked...
Just speculating (or dreaming)...
The halt is due to a major break in the SEC investigation into short trading in PVCT stock. Authorities are in the process of rounding up an extensive network of perpetrators and felt it necessary to suspend trading until they were all apprehended. This is organized crime and it is anticipated that they will be charged under the RICO statutes.
Writing the PR normally doesn't take that long. Getting it approved by the lawyers is usually what takes some time...
sboy777 asked...
FIFY - I feel like either the party's about to start or its gonna get crashed by A GANG OF CRIMINALS.
I'd love to see the cops (SEC) roll in on these manipulating basher bastards.
i07nyc said...
Countdown - BTD news in <1 day...
Probably means BTD news is about to be announced...
Shotor asked...
HALTED!
For all your cool shorts I'm sorry. For all you cocky ass shorts that only see through tunnel vision, I hope this has opened your mind.
Will today be the day or will the BTD question linger over a long holiday weekend?
That is a very good write-up! But to clarify, I NEVER lost confidence. And even if we don't get BTD, I'll still be here because I am that confident that PV-10 works; and that PVCT will monetize PV-10's success for us shareholders.
Don't sweat it. If you run out, just come on down to NC. For you, I got plenty...
123tom said...
I agree. That's why I support NNVC spending the money in legal fees to hold them accountable. Until somebody holds these criminals accountable they will continue to screw the retail investor. It's ridiculous that the SEC allows them to steal from people trying to save for college funds and retirement. The SEC is apparently useless when it comes to these short and distort schemes.
You n me both...
123tom said...
I could probably be persuaded to support selling Kevetrin to CELG or 72,000,000 shares of CELG. It's currently trading at ~$150 per share. That would be a current value of ~$100 per share of CTIX. I might consider a smaller number if a decent royalty were part of the deal. And we would still have B and P!
I'm enjoying this. Don't wake me up!
BK said...
TRUTH!
Detonate said...
It's called manipulation and it IS terrible and illegal. And when it is organized among multiple people, that is a conspiracy. That is also terrible AND illegal.
Goldie1971 said...
YES YOU CAN!!!
i07nyc said...
Somebody posted that SA was an Israeli owned company. Perhaps screwing US investors is how Mossad finances their black ops...
123tom said...